Plasma Concentration Studies
CJC-1295 / Ipamorelin
Mod GRF 1-29 + Ipamorelin
Modified GRF + Ipamorelin
CJC/Ipa Blend
A strategic peptide combination engineered to enhance gh release through synchronized GHRH and ghrelin receptor activation in experimental research models. Premium Research Peptide.
99%+ Purity
Purity Tested
Research Use Only
Laboratory Use
Peptide Profile
Peptide Type
Certificate of Analysis
Third Party Tested by Freedom Diagnostics
Compound Information
Technical specifications
GHRH Analog Component
Selective GHRP Component
Why This Combination
Sources & References
Peer-reviewed research
Journal of Clinical Endocrinology & Metabolism
Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-...
2006 • DOI: 10.1210/jc.2...
PMID: 16352683
Teichman SL, Neale A, Lawrence B et...
- View Source
European Journal of Endocrinology
Ipamorelin, the first selective growth hormone secretagogue
1998 • DOI: 10.1530/eje...
PMID: 9849822
Raun K, Hansen BS, Johansen NL et al.
- View Source
Journal of Clinical Endocrinology & Metabolism
On the actions of the growth hormone-releasing hexapeptide, GHRP
1991
PMID: 1919399
Bowers CY, Reynolds GA, Durham D e
- View Source
Translational Andrology and Urology
A Review of Growth Hormone Secretagogues
2018 • DOI: 10.21037/ta....
PMID: 30186644
Sigalos JT, Pastuszak AW
- View Source
Journal of Clinical Endocrinology & Metabolism
Effects of Growth Hormone and Its Secretagogues on Bone
1998
PMID: 9851737
Svensson J, Ohlsson C, Jansson JO et...
- View Source
Journal of Clinical Endocrinology & Metabolism
Once-Daily Administration of CJC-1295, a Long-Acting Growth Hormone-Releasing Hormone (GHR...
2006 • DOI: 10.1210/jc.2...
PMID: 16670169
Alba M, Fintini D, Sagazio A et al.
- View Source
